METHYL 5-(2-FLUOROPHENYL)-4-(HYDROXYMETHYL)-1,2-DIMETHYL-2-PYRROLIDINECARBOXYLATE
- $468 - $756
- Product name: METHYL 5-(2-FLUOROPHENYL)-4-(HYDROXYMETHYL)-1,2-DIMETHYL-2-PYRROLIDINECARBOXYLATE
- CAS: 1052611-84-3
- MF: C15H20FNO3
- MW: 281.32
- EINECS:
- MDL Number:MFCD09027167
- Synonyms:METHYL 5-(2-FLUOROPHENYL)-4-(HYDROXYMETHYL)-1,2-DIMETHYL-2-PYRROLIDINECARBOXYLATE;Proline, 5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethyl-, methyl ester
3 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerCrysdot
- Product numberCD21019160
- Product descriptionMethyl5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethylpyrrolidine-2-carboxylate 95+%
- Packaging1g
- Price$468
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047868
- Product descriptionMethyl 5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethyl-2-pyrrolidinecarboxylate >95%
- Packaging500mg
- Price$599
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047868
- Product descriptionMethyl 5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethyl-2-pyrrolidinecarboxylate >95%
- Packaging1g
- Price$756
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD21019160 | Methyl5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethylpyrrolidine-2-carboxylate 95+% | 1g | $468 | 2021-12-16 | Buy |
Matrix Scientific | 047868 | Methyl 5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethyl-2-pyrrolidinecarboxylate >95% | 500mg | $599 | 2021-12-16 | Buy |
Matrix Scientific | 047868 | Methyl 5-(2-fluorophenyl)-4-(hydroxymethyl)-1,2-dimethyl-2-pyrrolidinecarboxylate >95% | 1g | $756 | 2021-12-16 | Buy |
Properties
Boiling point :328.1±42.0 °C(Predicted)
Density :1.158±0.06 g/cm3(Predicted)
pka :14.93±0.10(Predicted)
Density :1.158±0.06 g/cm3(Predicted)
pka :14.93±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|